Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Estrogen receptor alpha (ERα) mRNA is the messenger RNA transcript produced from the ESR1 gene, which encodes the estrogen receptor alpha protein. ERα is a nuclear hormone receptor and functions as a ligand-activated transcription factor that regulates the expression of estrogen-responsive genes. The ESR1 gene undergoes alternative splicing, resulting in several mRNA transcripts that primarily differ in their 5' untranslated regions. Alterations or dysregulation of ESR1/ERα are implicated in various diseases, most notably breast cancer. It's the target for endocrine therapies such as selective estrogen receptor modulators/degraders. Mutations or splice variants can affect responsiveness to therapy or contribute to resistance mechanisms.
Modulation of ESR1 mRNA expression via various mechanisms
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Estrogen Receptor Alpha mRNA (None).